|
Sequent Scientific announced that its wholly owned subsidiary Alivira Animal Health through Alivira Ireland, has on 17 April 2018 signed an agreement with simultaneous closing to acquire 100% of Bremer Pharma, Zydus Cadila's Animal Health Business in Germany.
Bremer Pharma, founded in 1982 is a niche veterinary health company in Germany with focus on cattle and swine segments. Bremer has a portfolio of over 400+ registered products across Europe, Far East, MENA, Russia & Africa operating in vitamins, antibiotics and hormones. Bremer registered sales of €6.7Mn ($8.3Mn) in year ending March 31, 2018 with marginal losses. Bremer comes with a EUGMP compliant injectable
manufacturing facility with approval from German Competent Authority LANUV. The site was recently reinspected and obtained a renewed GMP certificate on 12 March 2018.
This acquisition provides Alivira's with a beta-lactam & non-beta lactam injectables facility for EU markets, which compliments its Orals & Powders beta-lactam and non-beta lactam facility based at Barcelona in Spain.
EU is Alivira's largest market accounting to 60% of revenues.
|